Healthcare provider profile · identity verified

Noah Ure Silver, MD

Family Practice · SEATTLE, WA · NPI 1144431461

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	565	168
Lisinopril	Lisinopril	283	93
Amlodipine Besylate	Amlodipine Besylate	246	74
Levothyroxine Sodium	Levothyroxine Sodium	191	48
Tamsulosin Hcl	Tamsulosin Hcl	165	61
Rosuvastatin Calcium	Rosuvastatin Calcium	164	48
Losartan Potassium	Losartan Potassium	132	43
Omeprazole	Omeprazole	132	48
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	123	38
Gabapentin	Gabapentin	117	34
Simvastatin	Simvastatin	108	30
Hydrochlorothiazide	Hydrochlorothiazide	99	32
Mirtazapine	Mirtazapine	88	22
Finasteride	Finasteride	72	23
Metformin Hcl	Metformin Hcl	72	22
Trazodone Hcl	Trazodone Hcl	69	25
Alendronate Sodium	Alendronate Sodium	66	20
Bupropion Xl	Bupropion Hcl	66	22
Potassium Chloride	Potassium Chloride	65	19
Allopurinol	Allopurinol	64	17
Furosemide	Furosemide	63	21
Escitalopram Oxalate	Escitalopram Oxalate	58	15
Fluticasone Propionate	Fluticasone Propionate	58	19
Jardiance	Empagliflozin	58	15
Alvesco	Ciclesonide	57	17
Metoprolol Succinate	Metoprolol Succinate	55	18
Albuterol Sulfate Hfa	Albuterol Sulfate	53	27
Sertraline Hcl	Sertraline Hcl	50	18
Citalopram Hbr	Citalopram Hydrobromide	49	15
Pantoprazole Sodium	Pantoprazole Sodium	49	16
Metformin Hcl Er	Metformin Hcl	46	12
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Famotidine	Famotidine	44	13
Atenolol	Atenolol	43	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	13
Fluoxetine Hcl	Fluoxetine Hcl	38	12
Estradiol	Estradiol	36	16
Clopidogrel	Clopidogrel Bisulfate	32	12
Acyclovir	Acyclovir	31	11
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Terazosin Hcl	Terazosin Hcl	31	suppressed
Lorazepam	Lorazepam	29	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	12
Carvedilol	Carvedilol	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	25	24
Valacyclovir	Valacyclovir Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	14
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	22	22
Azelastine Hcl	Azelastine Hcl	22	14
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	22	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	22	suppressed
Naltrexone Hcl	Naltrexone Hcl	22	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Meloxicam	Meloxicam	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Humulin N	Insulin Nph Human Isophane	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	16	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Azithromycin	Azithromycin	14	13
Estring	Estradiol	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Cephalexin	Cephalexin	13	12
Levetiracetam	Levetiracetam	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Prednisone	Prednisone	12	suppressed
Temazepam	Temazepam	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error